1. Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing
- Author
-
Li, Derun, primary, Sloman, David L., additional, Achab, Abdelghani, additional, Zhou, Hua, additional, McGowan, Meredeth A., additional, White, Catherine, additional, Gibeau, Craig, additional, Zhang, Hongjun, additional, Pu, Qinglin, additional, Bharathan, Indu, additional, Hopkins, Brett, additional, Liu, Kun, additional, Ferguson, Heidi, additional, Fradera, Xavier, additional, Lesburg, Charles A., additional, Martinot, Theodore A., additional, Qi, Ji, additional, Song, Zhiguo J., additional, Yin, Jingjun, additional, Zhang, Huangguang, additional, Song, Licheng, additional, Wan, Baoqiang, additional, DAddio, Suzanne, additional, Solban, Nicolas, additional, Miller, J. Richard, additional, Zamlynny, Beata, additional, Bass, Alan, additional, Freeland, Elizabeth, additional, Ykoruk, Bridget, additional, Hilliard, Catherine, additional, Ferraro, Jude, additional, Zhai, Jin, additional, Knemeyer, Ian, additional, Otte, Karin M., additional, Vincent, Stella, additional, Sciammetta, Nunzio, additional, Pasternak, Alexander, additional, Bennett, David Jonathan, additional, and Han, Yongxin, additional
- Published
- 2022
- Full Text
- View/download PDF